Details for New Drug Application (NDA): 060711
✉ Email this page to a colleague
NDA 060711 describes PENICILLIN-VK, which is a drug marketed by Teva and is included in two NDAs. It is available from six suppliers. Additional details are available on the PENICILLIN-VK profile page.
The generic ingredient in PENICILLIN-VK is penicillin v potassium. There are ninety-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
The generic ingredient in PENICILLIN-VK is penicillin v potassium. There are ninety-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
Summary for 060711
| Tradename: | PENICILLIN-VK |
| Applicant: | Teva |
| Ingredient: | penicillin v potassium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 060711
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PENICILLIN-VK | penicillin v potassium | TABLET;ORAL | 060711 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-1172 | 0093-1172-01 | 100 TABLET in 1 BOTTLE (0093-1172-01) |
| PENICILLIN-VK | penicillin v potassium | TABLET;ORAL | 060711 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-1172 | 0093-1172-10 | 1000 TABLET in 1 BOTTLE (0093-1172-10) |
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
